Xofluza OverviewBaloxavir marboxil (trade name Xofluza) is an antiviral medication for treatment of influenza A and influenza B FDA-approved in October 2018 and given as a single dose by mouth. It may reduce the duration of flu symptoms by about a day. It was developed by Shionogi Co., a Japanese pharmaceutical company, and Roche AG. Contents 1 Mechanism of action 2 Efficacy 3 Side effects 4 Resistance 5 Approval 6 References Mechanism of action Baloxavir marboxil is an influenza ...
Read more Xofluza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Baloxavir_marboxil
Recent Xofluza Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 20mg, 40mg
NDC Database Records for Xofluza: (4 results)Sorted by National Drug Code
- 50090-4102 Xofluza 20 mg Oral Tablet, Film Coated by A-s Medication Solutions
- 50090-4104 Xofluza 40 mg Oral Tablet, Film Coated by A-s Medication Solutions
- 50242-828 Xofluza 20 mg Oral Tablet, Film Coated by Genentech, Inc
- 50242-860 Xofluza 40 mg Oral Tablet, Film Coated by Genentech, Inc